- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Sclerosis, Systemic
Total 188647 results
-
Daval International LimitedUnknown
-
Boston UniversityAspreva PharmaceuticalsCompleted
-
Novartis PharmaceuticalsTerminatedRelapse Remitting Multiple SclerosisUnited States, Ukraine, Czechia
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
EMD SeronoPfizerCompletedRelapsing-remitting Multiple SclerosisUnited States, United Kingdom, Argentina, Austria, Brazil, France, Germany, Italy, Netherlands, Russian Federation, Spain, Switzerland
-
National Institute of Allergy and Infectious Diseases...Immune Tolerance Network (ITN)CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisUnited States, Spain, Germany, Australia, Sweden, Czechia, France, Italy, United Kingdom
-
Novartis PharmaceuticalsWithdrawnMultiple Sclerosis (Relapsing Remitting)
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisGermany
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
BayerCompletedRelapsing-Remitting Multiple SclerosisGermany
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, France, Mexico, Poland, Spain, Germany, Belarus, Estonia, Latvia, Romania, Ukraine, Israel, New Zealand, Slovakia, Greece, India, Serbia, Ireland, Costa Rica, Canada, Belgium, Macedonia,... and more
-
Novartis PharmaceuticalsWithdrawnRelapsing-remitting Multiple Sclerosis
-
Merck KGaA, Darmstadt, GermanyGesellschaft für Therapieforschung mbHCompleted
-
BiogenCompletedRelapsing-Remitting Multiple Sclerosis
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedRelapsing-Remitting Multiple SclerosisUnited States, Albania, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Estonia, Georgia, Greece, Latvia, Macedonia, The Former Yugoslav Republic of, Mexico, Moldova, Republic of, Montenegro, Poland, Romania, Russian... and more
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisNew Zealand, Australia
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
BiogenWithdrawn
-
Haukeland University HospitalPronova BioPharma; The Multiple Sclerosis National Competence Centre; The Norwegian... and other collaboratorsCompleted
-
Rennes University HospitalWyeth is now a wholly owned subsidiary of Pfizer; Bayer; Farmades, ItalyTerminatedRelapsing-Remitting Multiple SclerosisFrance, Italy
-
Novartis PharmaceuticalsActive, not recruitingRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Assistance Publique - Hôpitaux de ParisCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveFrance
-
Horizon Therapeutics USA, Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Talaris Therapeutics Inc.WithdrawnDiffuse Cutaneous Systemic SclerosisUnited States
-
Lawson Health Research InstituteSeagen Inc.CompletedDiffuse Cutaneous Systemic SclerosisCanada
-
Novartis PharmaceuticalsCompletedSystemic Sclerosis, SclerodermaUnited States, Germany, Italy, Switzerland, United Kingdom
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States
-
Corbus Pharmaceuticals Inc.TerminatedDiffuse Cutaneous Systemic SclerosisUnited States, Switzerland, Korea, Republic of, Australia, Netherlands, Israel, United Kingdom, Germany, Japan, Spain, Poland, Canada
-
Inventiva PharmaCompletedScleroderma, Diffuse | Diffuse Cutaneous Systemic SclerosisUnited Kingdom, France, Spain, Switzerland, Italy, Slovenia, Netherlands, Germany, Bulgaria, Poland
-
University of California, Los AngelesRecruitingPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University College DublinCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisIreland
-
Innate ImmunotherapeuticsNational Multiple Sclerosis Society; Primorus Clinical TrialsCompletedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisNew Zealand
-
University Hospital, Strasbourg, FranceRecruitingJuvenile Systemic SclerosisFrance
-
Rikshospitalet University HospitalTerminated
-
CelltrionNot yet recruitingRelapsing-remitting Multiple Sclerosis
-
Thomas Jefferson UniversityRecruitingRelapse Remitting Multiple SclerosisUnited States
-
Hikma Pharmaceuticals LLCActive, not recruitingRelapsing-Remitting Multiple SclerosisEgypt
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedRelapsing-remitting Multiple SclerosisUnited States, Germany
-
Charite University, Berlin, GermanyCompletedRelapsing-remitting Multiple SclerosisGermany
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
Assiut UniversityUnknownSimvastatin Multiple Sclerosis
-
Dimitrios KarussisCompletedMultiple Sclerosis (MS)Israel
-
Dr. Frank BehrensSocraMetrics GmbHCompleted
-
University of GlasgowNHS Ayrshire and Arran; AKMCompletedMultiple Sclerosis, ProgressiveUnited Kingdom
-
University of North Carolina, Chapel HillGenzyme, a Sanofi CompanyTerminatedRELAPSING REMITTING MULTIPLE SCLEROSISUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States